B
Dr. Reddy's Laboratories Limited RDY
$13.41 $0.141.05% NYSE
Recommendation
Prev Close
$13.27
Volume
683,089
Avg Vol (90D)
1,221,949
Market Cap
$10.92B
Dividend & Yield
$0.07(0.54%)
52-Week Range
$12.26 - $16.17
P/E (TTM)
17.01
EPS (TTM)
$0.78
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Dr. Reddy's Posts Q3 FY26 Earnings Call Transcript for Investors
1/27/2026 - TipRanks Financial Blog
Dr. Reddy's Q3 Earnings Call: Growth Amid Margin Strain
1/27/2026 - TipRanks Financial Blog
Dr Reddy's Laboratories Ltd (RDY) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst ...
1/26/2026 - GuruFocus
Q3 2026 Dr Reddy's Laboratories Ltd Earnings Call Transcript
1/25/2026 - GuruFocus
Non-US uptick seen driving gains for Dr Reddy's Labs
1/23/2026 - rediff Business
Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y
1/22/2026 - Zacks Investment Research
Dr. Reddy's Laboratories (RDY, $13.28) RSI Indicator left the oversold zone on January 21, 2026
1/22/2026 - Tickeron - Stocks
Dr Reddy's profit down 14% on low Lenalidomide US sales
1/22/2026 - rediff Business
Dr Reddy's Laboratories gains 5% on posting Q3 results; brokerages divided
1/22/2026 - Business Standard - Markets & Investing
Dr Reddy's Lab Q3 PAT drops 14% YoY to Rs 1,210 cr
1/22/2026 - Business Standard - Markets & Investing
Dr. Reddy's Laboratories Limited (RDY) Q3 2026 Earnings Call Transcript
1/21/2026 - SeekingAlpha
Dr. Reddy's Laboratories Limited (RDY) Q3 2026 Earnings Call Transcript
1/21/2026 - Seeking Alpha: India
Dr. Reddy's Laboratories Limited (RDY) Q3 2026 Earnings Call Transcript
1/21/2026 - Seeking Alpha: Transcripts
Dr. Reddy's Publishes Audio Recording of Q3 FY2026 Earnings Call
1/21/2026 - TipRanks Financial Blog
Dr. Reddy's Laboratories (NYSE:RDY) Posts Quarterly Earnings Results, Hits Expectations
1/21/2026 - Ticker Report
Dr. Reddy's Laboratories (NYSE:RDY) Issues Earnings Results
1/21/2026 - MarketBeat
Dr. Reddy's Laboratories Q3 Earnings Call Highlights
1/21/2026 - Yahoo! Finance: News
Dr. Reddy's Laboratories Q3 Earnings Call Highlights
1/21/2026 - MarketBeat
Dr Reddy's Q3 PAT down 14% Y-o-Y on low Lenalidomide sales in US
1/21/2026 - Business Standard - Companies & Industry
Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter
1/21/2026 - Business Standard - Markets & Investing
Dr. Reddy's Laboratories Ltd $RDY Shares Sold by Campbell & CO Investment Adviser LLC
1/21/2026 - MarketBeat
Short Interest in Dr. Reddy's Laboratories Ltd (NYSE:RDY) Increases By 21.7%
1/20/2026 - MarketBeat
Dr. Reddy's Laboratories (RDY, $13.09) RSI Indicator left the oversold zone on January 15, 2026
1/16/2026 - Tickeron - Technical Analysis
Nifty 50 Index forecast ahead of ICICI, HDFC, Yes Bank earnings
1/16/2026 - Invezz News
Dr. Reddy's Laboratories (RDY) Projected to Post Earnings on Thursday
1/15/2026 - MarketBeat
Income Statement
Total Revenue (TTM)
$3.97B
EBITDA (TTM)
$962.24M
EBIT (TTM)
$752.00M
Net Income (TTM)
$650.25M
Balance Sheet
Total Assets (Q)
$6.26B
Total Debt (Q)
$753.78M
Total Liabilities (Q)
$2.08B
Book Value Per Share (Q)
$4.98
Cash Flow
Cash from Operations (TTM)
$725.90M
Cash from Investing (TTM)
-$602.77M
Cash from Financing (TTM)
-$72.87M
Net Change in Cash (TTM)
$61.29M
Filings
Filing Date
Wednesday, January 21, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Jun 1 and 5 (est)
Price History
Loading...
Beta
0.30
7-Day Total Return
0.98%
30-Day Total Return
-3.60%
60-Day Total Return
0.00%
90-Day Total Return
-8.15%
Year to Date Total Return
-3.25%
1-Year Total Return
-2.42%
2-Year Total Return
-2.42%
3-Year Total Return
27.28%
5-Year Total Return
16.28%
52-week Low
Apr 09, 2025 - $12.26
52-week High
Jun 12, 2025 - $16.17
Valuation
Market Cap
$10.92B - Large Cap
Enterprise Value
$10.80B
Price/Sales (TTM)
2.79
Price/Book (Q)
2.67
Dividends and Shares
Shares Outstanding
833.20M
Dividend Per Share (Most Recent)
$0.07
Dividend Per Share (TTM)
$0.07
Corporate Info
Website
www.drreddys.com
Phone Number
91 40 4900 2900
Address
8-2-337, Road No. 3
Hyderabad, 500034
Country
India
Year Founded
1984
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through... more
NYSE 01/30/2026 1:24PM Eastern Quotes delayed